Lymphoma of the marginal nodal zone with positive CD5 marker, report of a case in an adolescent patient
DOI:
https://doi.org/10.5281/zenodo.20134224Keywords:
lymphoma, marginal zone, positive CD 5 markerAbstract
In this moment, there are three types of marginal zone lymphoma (MZL) they are: MZL splenic LZM, extranodal LZM (MALT lymphoma) and primary lymph node LZM (NM LZM). These kinds of lymphomas have morphological and phenotypic characteristics that somewhat overlapping so different in clinical presentation and behavior. In the same vein, the marginal zone lymphoma (LMZ) it is an indolent mature B-cell neoplasm with variable clinical presentation and distinctive histopathological features. As mentioned above, there is a case of a 15-year-old female adolescent. She is from Anzoátegui state, Venezuela. Her parents are non-consanguineous, with a personal youth history of polyp polypectomy, and paroxysmal disorder (corrected), competent mitral valve prolapse, inborn error of immunity: common variable immunodeficiency, infection by Epstein-Barr Virus and Hepatitis C Virus. She has a Family history of hemoglobinopathy in her father and brother. Her brother died of Acute Lymphoblastic Leukemia. Who presented a medical condition for twelve (12) months with intermittent fever, cutaneous mucosal sickly, polyarthralgia, diffuse perumbilical abdominal pain, abdominal distension, hyporexia, asthenia, weight loss, cervical, axillary and inguinals adenomegaly, with nephromegaly, subsequently associated with dizziness, erythematous maculopapular lesions on the face and lower limbs, with persistence of febrile episodes, which temporarily improve with the use of oral steroid for four (4) months. Multidisciplinary evaluations were performed, which included cervical lymph node excision, resulting in immunohistochemical findings compatible with CD5-positive lymphoma of the Marginal Zone Lymph Node, for which the pertinent bibliographic review was carried out.
Downloads
References
Cheah y Seymour (2023) Linfoma de la zona marginal: actualización 2023 sobre diagnóstico y tratamiento. Volumen98, Número10. octubre 2023 Páginas 1645-1657. Disponible en: Revista Americana de Hematología | Revista de Investigación de la Sangre | Biblioteca en línea de Wiley
Laurent, C., Cook, J.R., Yoshino, T. et al. (2023) Follicular lymphoma and marginal zone lymphoma: how many diseases? Virchow’s Arch 482, 149–162 (2023). Disponible en: Follicular lymphoma and marginal zone lymphoma: how many diseases? | Virchows Archiv
De Leval, L., & Jaffe, E. S. (2020). Lymphoma Classification. The Cancer Journal, 26(3), 176–185. Disponible en: https://journals.lww.com/journalppo/abstract/2020/05000/lymphoma_classification.2.aspx
Sindel, A., Al-Juhaishi, T., & Yazbeck, V. (2019). Linfoma de la zona marginal: tratamiento de última generación. Opciones de tratamiento actuales en oncología, 20(12). Linfoma de la zona marginal: tratamiento de última generación | Opciones de tratamiento actuales en oncología
Taddesse-Heath, Lekidelu M.D.; Pittaluga, Dra. Stefania; Sorbara, Lynn Ph.D.; Bussey, María; Raffeld, Mark M.D.; Jaffe, Elaine S. M.D. Linfoma de células B de la zona marginal en niños y adultos jóvenes. Revista Americana de Patología Quirúrgica 27(4): p. 522-531, abril de 2003. Disponible en: https://journals.lww.com/ajsp/abstract/2003/04000/marginal_zone_b_cell_lymphoma_in_children_and.14.aspx
Jaso, J. M., Yin, C. C., Wang, S. A., Miranda, R. N., Jabcuga, C. E., Chen, L., & Medeiros, L. J. (2013). Clinicopathologic Features of CD5-Positive Nodal Marginal Zone Lymphoma. American Journal of Clinical Pathology, 140(5), 693–700. Disponible en: Clinicopathologic Features of CD5-Positive Nodal Marginal Zone Lymphoma | American Journal of Clinical Pathology | Oxford Academic
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Derechos del/de autor/es a partir del año de publicación
Esta obra está bajo la licencia:
Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
Las opiniones expresadas por los autores no necesariamente reflejan la postura del editor de la publicación ni de la UCLA. Se autoriza la reproducción total o parcial de los textos aquí publicados, siempre y cuando se cite la fuente completa y la dirección electrónica de esta revista. Los autores(as) tienen el derecho de utilizar sus artículos para cualquier propósito siempre y cuando se realice sin fines de lucro. Los autores(as) pueden publicar en internet o cualquier otro medio la versión final aprobada de su trabajo, luego que esta ha sido publicada en esta revista.
